4 patents
Utility
Methods for treatment of polycystic kidney disease
9 Nov 21
Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
John R. Androsavich, B. Nelson Chau, Vishal D. Patel
Filed: 19 Mar 20
Utility
Compounds and methods for enhanced cellular uptake
9 Mar 21
Described herein are conjugated modified oligonucleotides that are complementary to a target RNA.
Balkrishen Bhat
Filed: 17 Jan 19
Utility
Methods for treatment of polycystic kidney disease
27 Apr 20
Provided herein are methods for the treatment of poly-cystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17.
John R. Androsavich, B. Nelson Chau, Vishal D. Patel
Filed: 24 Aug 16
Utility
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
9 Mar 20
Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs.
C. Frank Bennett, Susan M. Freier, Richard H. Griffey
Filed: 5 Sep 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first